MNKD
MannKind Corporation
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Michael E. Castagna
IPO Date
2004-07-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
MannKind Corporation
CEO
Michael E. Castagna
IPO Date
2004-07-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 10,000 |
| $2.95 |
| 22 May 2026 | Consiglio Ronald J | director | A-Award | Acquired | 82,781 | $0.00 |
| 22 May 2026 | Consiglio Ronald J | director | A-Award | Acquired | 16,556 | $0.00 |
| 22 May 2026 | Binder Steven B. | director | A-Award | Acquired | 82,781 | $0.00 |
| 22 May 2026 | Grancio Jennifer | director | A-Award | Acquired | 82,781 | $0.00 |
| 22 May 2026 | HOOPER ANTHONY C | director | A-Award | Acquired | 82,781 | $0.00 |
| 22 May 2026 | HOOPER ANTHONY C | director | A-Award | Acquired | 16,556 | $0.00 |
| 22 May 2026 | Shannon James Samuel | director | A-Award | Acquired | 82,781 | $0.00 |
| 22 May 2026 | Shannon James Samuel | director | A-Award | Acquired | 16,556 | $0.00 |